Status:

TERMINATED

Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia

Lead Sponsor:

Northwell Health

Conditions:

Diamond Blackfan Anemia

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study is to determine the safety and dosing of drug Sotatercept, as a subcutaneous injection, to stimulate production of red blood cell production. To be given every 28 days for up...

Detailed Description

This study is for adult patients with Diamond Blackfan Anemia who are currently being transfused every 3- 4 weeks. The drug will be given as a subcutaneous injection within one of three dose levels. ...

Eligibility Criteria

Inclusion

  • \>/= 18 years of age
  • DBA diagnosed
  • RBC transfusion- dependence (defined as \>/= 10 cc/kg of RBC per 28 days average)
  • Karnofsky performance scale \>/= 70
  • Females of childbearing potential are to use birth control during study participation and for 112 days following the last dose of sotatercept
  • Males must agree to use a latex condom during any sexual contact with females of childbearing potential while participating in the study and for 112 days following the last dose of sotatercept
  • Agreement to adhere to the study visit schedule, understand and comply with all protocol requirements
  • Understand and sign a written informed consent

Exclusion

  • Creatinine clearance \< 30 ml/min
  • SGOT \> 3x upper limit of normal, SGPT \> 3x upper limit normal, or bilirubin \>3x upper limit normal
  • Heart disease (NY Heart Association classification of \>/= 3
  • History of hypertension
  • Subjects currently responsive to corticosteroids for treatment of Diamond Blackfan anemia
  • Treatment with another investigational drug or device \<56 days pre-study entry
  • Pregnant or lactating females
  • Cancer

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 13 2021

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT01464164

Start Date

January 1 2012

End Date

April 13 2021

Last Update

March 17 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

North Shore- LIJ campus of The Feinstein Institute for Medical Research

Manhasset, New York, United States, 11030

Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia | DecenTrialz